Athlete biological passport: longitudinal biomarkers and statistics in the fight against doping

1. World Anti-Doping Agency (WADA). World Anti-Doping Code [displayed 17 January 2023]. Available at https://www.wada-ama.org/sites/default/files/resources/files/2021_wada_code.pdf World Anti-Doping Agency (WADA) World Anti-Doping Code [displayed 17 January 2023] Available at https://www.wada-ama.org/sites/default/files/resources/files/2021_wada_code.pdf Search in Google Scholar

2. Ljungqvist A. Brief history of anti-doping. Med Sport Sci 2017;62:1–10. doi: 10.1159/000460680 LjungqvistA Brief history of anti-doping Med Sport Sci 2017 62 1 10 10.1159/000460680 Open DOISearch in Google Scholar

3. Santalla A, Earnest C, Rodriguez-Marroyo J, Lucia A. The Tour de France: an updated physiological review. Int J Sports Physiol Perform 2012;7:200–9. doi: 10.1123/ijspp.7.3.200 SantallaA EarnestC Rodriguez-MarroyoJ LuciaA The Tour de France: an updated physiological review Int J Sports Physiol Perform 2012 7 200 9 10.1123/ijspp.7.3.200 Open DOISearch in Google Scholar

4. Mørkeberg J. Blood manipulation: current challenges from an anti-doping perspective. Hematology Am Soc Hematol Educ Program 2013;2013:627–31. doi: 10.1182/asheducation-2013.1.627 MørkebergJ Blood manipulation: current challenges from an anti-doping perspective Hematology Am Soc Hematol Educ Program 2013 2013 627 31 10.1182/asheducation-2013.1.627 Open DOISearch in Google Scholar

5. World Anti-Doping Agency (WADA). Coordinating Investigations and Sharing Anti-Doping Information and Evidence, 2011 [displayed 14 April 2023]. Available at https://www.wada-ama.org/sites/default/files/resources/files/WADA_Investigations_Guidelines_May2011_EN.pdf World Anti-Doping Agency (WADA) Coordinating Investigations and Sharing Anti-Doping Information and Evidence 2011 [displayed 14 April 2023]. Available at https://www.wada-ama.org/sites/default/files/resources/files/WADA_Investigations_Guidelines_May2011_EN.pdf Search in Google Scholar

6. Plumb JOM, Otto JM, Grocott MPW. “Blood doping” from Armstrong to prehabilitation: manipulation of blood to improve performance in athletes and physiological reserve in patients. Extrem Physiol Med 2016;5:5. doi: 10.1186/s13728-016-0046-0 PlumbJOM OttoJM GrocottMPW “Blood doping” from Armstrong to prehabilitation: manipulation of blood to improve performance in athletes and physiological reserve in patients Extrem Physiol Med 2016 5 5 10.1186/s13728-016-0046-0 Open DOISearch in Google Scholar

7. de Oliveira CDR, de Bairros AV, Yonamine M. Blood doping: risks to athletes’ health and strategies for detection. Subst Use Misuse 2014;49:1168–81. doi: 10.3109/10826084.2014.903754 de OliveiraCDR de BairrosAV YonamineM Blood doping: risks to athletes’ health and strategies for detection Subst Use Misuse 2014 49 1168 81 10.3109/10826084.2014.903754 Open DOISearch in Google Scholar

8. Cazzola M. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Haematologica 2000;85:561–3. PMID: 10870110 CazzolaM A global strategy for prevention and detection of blood doping with erythropoietin and related drugs Haematologica 2000 85 561 3 10870110 Search in Google Scholar

9. Johansson PI, Ullum H, Jensen K, Secher NH. A retrospective cohort study of blood hemoglobin levels in blood donors and competitive rowers. Scand J Med Sci Sports 2009;19:92–5. doi: 10.1111/j.1600-0838.2008.00771.x JohanssonPI UllumH JensenK SecherNH A retrospective cohort study of blood hemoglobin levels in blood donors and competitive rowers Scand J Med Sci Sports 2009 19 92 5 10.1111/j.1600-0838.2008.00771.x Open DOISearch in Google Scholar

10. World Anti-Doping Agency (WADA). WADA’s Athlete Biological Passport: an important tool for protecting clean sport, 2021 [displayed 2023 Jan 18]. Available at https://www.wada-ama.org/en/news/wadas-athlete-biological-passport-important-tool-protecting-clean-sport World Anti-Doping Agency (WADA) WADA’s Athlete Biological Passport: an important tool for protecting clean sport 2021 [displayed 2023 Jan 18]. Available at https://www.wada-ama.org/en/news/wadas-athlete-biological-passport-important-tool-protecting-clean-sport Search in Google Scholar

11. Dunn JOC, Mythen MG, Grocott MP. Physiology of oxygen transport. BJA Education 2016;16:341–8. doi: 10.1093/bjaed/mkw012 DunnJOC MythenMG GrocottMP Physiology of oxygen transport BJA Education 2016 16 341 8 10.1093/bjaed/mkw012 Open DOISearch in Google Scholar

12. Bailey DM, Davies B. Physiological implications of altitude training for endurance performance at sea level: a review. Br J Sports Med 1997;31:183–90. doi: 10.1136/bjsm.31.3.183 BaileyDM DaviesB Physiological implications of altitude training for endurance performance at sea level: a review Br J Sports Med 1997 31 183 90 10.1136/bjsm.31.3.183 Open DOISearch in Google Scholar

13. Sitkowski D, Szygula Z, Pokrywka A, Turowski D, Malczewska-Lenczowska J. Interrelationships between changes in erythropoietin, plasma volume, haemoglobin concentration, and total haemoglobin mass in endurance athletes. Res Sports Med 2018;26:381–9. doi: 10.1080/15438627.2018.1447936 SitkowskiD SzygulaZ PokrywkaA TurowskiD Malczewska-LenczowskaJ Interrelationships between changes in erythropoietin, plasma volume, haemoglobin concentration, and total haemoglobin mass in endurance athletes Res Sports Med 2018 26 381 9 10.1080/15438627.2018.1447936 Open DOISearch in Google Scholar

14. Dragcevic D, Jaksic O. Blood doping - physiological background, substances and techniques used, current and future detection methods. Sci Sports 2023;38:498–509. doi: 10.1016/j.scispo.2022.12.003 DragcevicD JaksicO Blood doping - physiological background, substances and techniques used, current and future detection methods Sci Sports 2023 38 498 509 10.1016/j.scispo.2022.12.003 Open DOISearch in Google Scholar

15. World Anti-Doping Agency (WADA). Athlete Biological Passport Operating Guidelines, 2021 [displayed 17 January 2023]. Available at https://www.wada-ama.org/sites/default/files/resources/files/guidelines_abp_v8_final.pdf World Anti-Doping Agency (WADA) Athlete Biological Passport Operating Guidelines 2021 [displayed 17 January 2023]. Available at https://www.wada-ama.org/sites/default/files/resources/files/guidelines_abp_v8_final.pdf Search in Google Scholar

16. Saugy M, Lundby C, Robinson N. Monitoring of biological markers indicative of doping: The athlete biological passport. Br J Sports Med 2014;48:827–32. doi: 10.1136/bjsports-2014-093512 SaugyM LundbyC RobinsonN Monitoring of biological markers indicative of doping: The athlete biological passport Br J Sports Med 2014 48 827 32 10.1136/bjsports-2014-093512 Open DOISearch in Google Scholar

17. Giraud S, Robinson N, Mangin P, Saugy M. Scientific and forensic standards for homologous blood transfusion anti-doping analyses. Forensic Sci Int 200;179:23–33. doi: 10.1016/j.forsciint.2008.04.007 GiraudS RobinsonN ManginP SaugyM Scientific and forensic standards for homologous blood transfusion anti-doping analyses Forensic Sci Int 200 179 23 33 10.1016/j.forsciint.2008.04.007 Open DOISearch in Google Scholar

18. Robinson N, Sottas P-E, Mangin P, Saugy M. Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes. Haematologica 2007;92:1143–4. doi: 10.3324/haematol.11182 RobinsonN SottasP-E ManginP SaugyM Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes Haematologica 2007 92 1143 4 10.3324/haematol.11182 Open DOISearch in Google Scholar

19. Sottas PE, Robinson N, Saugy M. The athlete’s biological passport and indirect markers of blood doping. In: Thieme D, Hemmersbach P, editors. Doping in Sports: Biochemical Principles, Effects and Analysis. Handbook of Experimental Pharmacolgy. Vol. 195. Berlin, Heidelberg: Springer; 2010. p. 305–26. doi: 10.1007/978-3-540-79088-4_14 SottasPE RobinsonN SaugyM The athlete’s biological passport and indirect markers of blood doping In ThiemeD HemmersbachP editors Doping in Sports: Biochemical Principles, Effects and Analysis. Handbook of Experimental Pharmacolgy 195 Berlin, Heidelberg Springer 2010 305 26 10.1007/978-3-540-79088-4_14 Open DOISearch in Google Scholar

20. Robinson N, Sottas PE, Pottgiesser T, Schumacher YO, Saugy M. Stability and robustness of blood variables in an antidoping context. Int J Lab Hematol 2011;33:146–53. doi: 10.1111/j.1751-553X.2010.01256.x RobinsonN SottasPE PottgiesserT SchumacherYO SaugyM Stability and robustness of blood variables in an antidoping context Int J Lab Hematol 2011 33 146 53 10.1111/j.1751-553X.2010.01256.x Open DOISearch in Google Scholar

21. Sottas PE, Robinson N, Saugy M, Niggli O. A forensic approach to the interpretation of blood doping markers. Law Probab Risk 2008;7:191–210. doi: 10.1093/lpr/mgm042 SottasPE RobinsonN SaugyM NiggliO A forensic approach to the interpretation of blood doping markers Law Probab Risk 2008 7 191 210 10.1093/lpr/mgm042 Open DOISearch in Google Scholar

22. Hollowell JG, van Assendelft OW, Gunter EW, Lewis BG, Najjar M, Pfeiffer C; Centers for Disease Control and Prevention, National Center for Health Statistics. Hematological and iron-related analytes - reference data for persons aged 1 year and over: United States, 1988–94. Vital Health Stat Ser. 11 2005;(247):1–156. PMID: 15782774 HollowellJG van AssendelftOW GunterEW LewisBG NajjarM PfeifferC Centers for Disease Control and Prevention, National Center for Health Statistics Hematological and iron-related analytes - reference data for persons aged 1 year and over: United States, 1988–94 Vital Health Stat Ser. 11 2005 247 1 156 15782774 Search in Google Scholar

23. Jorgensen JM, Crespo-Bellido M, Dewey KG. Variation in hemoglobin across the life cycle and between males and females. Ann N Y Acad Sci 2019;1450:105–25. doi: 10.1111/nyas.14096 JorgensenJM Crespo-BellidoM DeweyKG Variation in hemoglobin across the life cycle and between males and females Ann N Y Acad Sci 2019 1450 105 25 10.1111/nyas.14096 Open DOISearch in Google Scholar

24. Murphy WG. The sex difference in haemoglobin levels in adults - Mechanisms, causes, and consequences. Blood Rev 2014;28:41–7. doi: 10.1016/j.blre.2013.12.003 MurphyWG The sex difference in haemoglobin levels in adults - Mechanisms, causes, and consequences Blood Rev 2014 28 41 7 10.1016/j.blre.2013.12.003 Open DOISearch in Google Scholar

25. Adeli K, Raizman JE, Chen Y, Higgins V, Nieuwesteeg M, Abdelhaleem M, Wong SL, Blais D. Complex biological profile of hematologic markers across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey. Clin Chem 2015;61:1075–86. doi: 10.1373/clinchem.2015.240531 AdeliK RaizmanJE ChenY HigginsV NieuwesteegM AbdelhaleemM WongSL BlaisD Complex biological profile of hematologic markers across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey Clin Chem 2015 61 1075 86 10.1373/clinchem.2015.240531 Open DOISearch in Google Scholar

26. Lim E, Miyamura J, Chen JJ. Racial/ethnic-specific reference intervals for common laboratory tests: a comparison among Asians, Blacks, Hispanics, and White. Hawaii J Med Public Health 2015;74:302–10. PMCID: PMC4578165 LimE MiyamuraJ ChenJJ Racial/ethnic-specific reference intervals for common laboratory tests: a comparison among Asians, Blacks, Hispanics, and White Hawaii J Med Public Health 2015 74 302 10 PMC4578165 Search in Google Scholar

27. Beutler E, West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and α-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 2005;106:740–5. doi: 10.1182/blood-2005-02-0713 BeutlerE WestC Hematologic differences between African-Americans and whites: the roles of iron deficiency and α-thalassemia on hemoglobin levels and mean corpuscular volume Blood 2005 106 740 5 10.1182/blood-2005-02-0713 Open DOISearch in Google Scholar

28. Ghosh AK. Anaerobic threshold: its concept and role in endurance sport. Malays J Med Sci 2004;11:24–36. PMCID: PMC3438148 GhoshAK Anaerobic threshold: its concept and role in endurance sport Malays J Med Sci 2004 11 24 36 PMC3438148 Search in Google Scholar

29. Heinicke K, Wolfarth B, Winchenbach P, Biermann B, Schmid A, Huber G, Friedmann B, Schmidt W. Blood volume and hemoglobin mass in elite athletes of different disciplines. Int J Sports Med 2001;22:504–12. doi: 10.1055/s-2001-17613 HeinickeK WolfarthB WinchenbachP BiermannB SchmidA HuberG FriedmannB SchmidtW Blood volume and hemoglobin mass in elite athletes of different disciplines Int J Sports Med 2001 22 504 12 10.1055/s-2001-17613 Open DOISearch in Google Scholar

30. Mairbäurl H. Red blood cells in sports: effects of exercise and training on oxygen supply by red blood cells. Front Physiol 2013;4:332. doi: 10.3389/fphys.2013.00332 MairbäurlH Red blood cells in sports: effects of exercise and training on oxygen supply by red blood cells Front Physiol 2013 4 332 10.3389/fphys.2013.00332 Open DOISearch in Google Scholar

31. Lobigs LM, Sharpe K, Garvican-Lewis LA, Gore CJ, Peeling P, Dawson B, Schumacher YO. The athlete’s hematological response to hypoxia: A meta-analysis on the influence of altitude exposure on key biomarkers of erythropoiesis. Am J Hematol 2018;93:74–83. doi: 10.1002/ajh.24941 LobigsLM SharpeK Garvican-LewisLA GoreCJ PeelingP DawsonB SchumacherYO The athlete’s hematological response to hypoxia: A meta-analysis on the influence of altitude exposure on key biomarkers of erythropoiesis Am J Hematol 2018 93 74 83 10.1002/ajh.24941 Open DOISearch in Google Scholar

32. Garvican-Lewis LA, Sharpe K, Gore KJ. Time for a new metric for hypoxic dose? J Appl Physiol 2016;121:352–5. doi: 10.1152/japplphysiol.00579.2015 Garvican-LewisLA SharpeK GoreKJ Time for a new metric for hypoxic dose? J Appl Physiol 2016 121 352 5 10.1152/japplphysiol.00579.2015 Open DOISearch in Google Scholar

33. Acar UA, Ihler AT, Mettu RR, Sumer O. Adaptive Bayesian Inference. NIPS 2007 [displayed 10 March 2023]. Available at https://www.semanticscholar.org/paper/Adaptive-Bayesian-inference-Acar-Ihler/85cd2ab6e53f1565922d7764c44865af4739f68c AcarUA IhlerAT MettuRR SumerO Adaptive Bayesian Inference NIPS 2007 [displayed 10 March 2023]. Available at https://www.semanticscholar.org/paper/Adaptive-Bayesian-inference-Acar-Ihler/85cd2ab6e53f1565922d7764c44865af4739f68c Search in Google Scholar

34. Montagna S, Hopker J. A Bayesian approach for the use of athlete performance data within anti-doping. Front Physiol 2018;9:884. doi: 10.3389/fphys.2018.00884 MontagnaS HopkerJ A Bayesian approach for the use of athlete performance data within anti-doping Front Physiol 2018 9 884 10.3389/fphys.2018.00884 Open DOISearch in Google Scholar

35. Krumm B, Botrè F, Saugy JJ, Faiss R. Future opportunities for the Athlete Biological Passport. Front Sports Act Living 2022;4:986875. doi: 10.3389/fspor.2022.986875 KrummB BotrèF SaugyJJ FaissR Future opportunities for the Athlete Biological Passport Front Sports Act Living 2022 4 986875 10.3389/fspor.2022.986875 Open DOISearch in Google Scholar

36. Zorzoli M. Biological passport parameters. J Hum Sport Exerc 2011;6:205–17. doi: 10.4100/jhse.2011.62.02 ZorzoliM Biological passport parameters J Hum Sport Exerc 2011 6 205 17 10.4100/jhse.2011.62.02 Open DOISearch in Google Scholar

37. Schütz F, Zollinger A. ABPS: An R package for calculating the abnormal blood profile score. Front Physiol 2018;9:1638. doi: 10.3389/fphys.2018.01638 SchützF ZollingerA ABPS: An R package for calculating the abnormal blood profile score Front Physiol 2018 9 1638 10.3389/fphys.2018.01638 Open DOISearch in Google Scholar

38. Zorzoli M, Rossi F. Implementation of the biological passport: the experience of the International Cycling Union. Drug Test Anal 2010;2:542–7. doi: 10.1002/dta.173 ZorzoliM RossiF Implementation of the biological passport: the experience of the International Cycling Union Drug Test Anal 2010 2 542 7 10.1002/dta.173 Open DOISearch in Google Scholar

39. Robinson N, Saugy M, Vernec A, Pierre-Edouard S. The athlete biological passport: an effective tool in the fight against doping. Clin Chem 2011;57:830–2. doi: 10.1373/clinchem.2011.162107 RobinsonN SaugyM VernecA Pierre-EdouardS The athlete biological passport: an effective tool in the fight against doping Clin Chem 2011 57 830 2 10.1373/clinchem.2011.162107 Open DOISearch in Google Scholar

40. Banfi G, Lombardi G, Colombini A, Lippi G. Analytical variability in sport hematology: its importance in an antidoping setting. Clin Chem Lab Med 2011;49:779–82. doi: 10.1515/CCLM.2011.125 BanfiG LombardiG ColombiniA LippiG Analytical variability in sport hematology: its importance in an antidoping setting Clin Chem Lab Med 2011 49 779 82 10.1515/CCLM.2011.125 Open DOISearch in Google Scholar

41. World Anti-Doping Agency (WADA). ADEL [displayed 25 February 2023]. Available at https://adel.wada-ama.org/en/node/335/take World Anti-Doping Agency (WADA) ADEL [displayed 25 February 2023]. Available at https://adel.wada-ama.org/en/node/335/take Search in Google Scholar

42. World Anti-Doping Agency (WADA). WADA welcomes enhanced long-term sample storage and re-analysis program [displayed 21 February 2023]. Available at https://www.wada-ama.org/en/news/wada-welcomes-enhanced-long-term-sample-storage-and-re-analysis-program World Anti-Doping Agency (WADA) WADA welcomes enhanced long-term sample storage and re-analysis program [displayed 21 February 2023] Available at https://www.wada-ama.org/en/news/wada-welcomes-enhanced-long-term-sample-storage-and-re-analysis-program Search in Google Scholar

43. World Anti-Doping Agency (WADA). Athlete Biological Passport (ABP) Custodianship and Information Sharing [displayed 1 February 2023]. Available at https://www.wada-ama.org/sites/default/files/resources/files/abp-passport-custodianship-sharing-information-final_0.pdf World Anti-Doping Agency (WADA) Athlete Biological Passport (ABP) Custodianship and Information Sharing [displayed 1 February 2023] Available at https://www.wada-ama.org/sites/default/files/resources/files/abp-passport-custodianship-sharing-information-final_0.pdf Search in Google Scholar

44. Mullen J, Baekken L, Bergström H, Björkhem Bergman L, Ericsson M, Ekström L. Fluctuations in hematological athlete biological passport biomarkers in relation to the menstrual cycle. Drug Test Anal 2020;12:1229–40. doi: 10.1002/dta.2873 MullenJ BaekkenL BergströmH Björkhem BergmanL EricssonM EkströmL Fluctuations in hematological athlete biological passport biomarkers in relation to the menstrual cycle Drug Test Anal 2020 12 1229 40 10.1002/dta.2873 Open DOISearch in Google Scholar

45. Bellemare V, Faucher F, Breston R, Van Luu T. Characterization of 17α hydroxysteroid dehydrogenase activity (17α HSD) and its involvement in biosynthesis of epitestosterone. BMC Biochem 2005;6:12. doi: 10.1186/1471-2091-6-12 BellemareV FaucherF BrestonR Van LuuT Characterization of 17α hydroxysteroid dehydrogenase activity (17α HSD) and its involvement in biosynthesis of epitestosterone BMC Biochem 2005 6 12 10.1186/1471-2091-6-12 Open DOISearch in Google Scholar

46. Aguilera R, Hatton CK, Catlin DH. Detection of epitestosterone doping by isotope ratio mass spectrometry. Clin Chem 2002;48:629–36. doi: 10.1093/clinchem/48.4.629 AguileraR HattonCK CatlinDH Detection of epitestosterone doping by isotope ratio mass spectrometry Clin Chem 2002 48 629 36 10.1093/clinchem/48.4.629 Open DOISearch in Google Scholar

47. Van Eenoo P, Delbeke FT. Metabolism and excretion of anabolic steroids in doping control - New steroids and new insights. J Steroid Biochem Mol Biol 2006;101:161–78. doi: 10.1016/j.jsbmb.2006.06.024 Van EenooP DelbekeFT Metabolism and excretion of anabolic steroids in doping control - New steroids and new insights J Steroid Biochem Mol Biol 2006 101 161 78 10.1016/j.jsbmb.2006.06.024 Open DOISearch in Google Scholar

48. Bowers LD. Testosterone doping: dealing with genetic differences in metabolism and excretion. J Clin Endocrinol Metab 2008;93:2469–71. doi: 10.1210/jc.2008-0977 BowersLD Testosterone doping: dealing with genetic differences in metabolism and excretion J Clin Endocrinol Metab 2008 93 2469 71 10.1210/jc.2008-0977 Open DOISearch in Google Scholar

49. Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol 2008;154:502–21. doi: 10.1038/bjp.2008.165 KicmanAT Pharmacology of anabolic steroids Br J Pharmacol 2008 154 502 21 10.1038/bjp.2008.165 Open DOISearch in Google Scholar

50. Death AK, McGrath KCY, Kazlauskas R, Handelsman DJ. Tetrahydrogestrinone is a potent androgen and progestin. J Clin Endocrinol Metab 2004;89:2498–500. doi: 10.1210/jc.2004-0033 DeathAK McGrathKCY KazlauskasR HandelsmanDJ Tetrahydrogestrinone is a potent androgen and progestin J Clin Endocrinol Metab 2004 89 2498 500 10.1210/jc.2004-0033 Open DOISearch in Google Scholar

51. Martín-Escudero P, Muñoz-Guerra J, Del Prado N, Galindo Canales M, Fuentes Ferrer M, Vargas S, Soldevilla AB, Serrano-Garde E, Miguel-Tobal F, Maestro de Las Casas M, Fernandez-Pérez C. Impact of UGT2B17 gene deletion on the steroid profile of an athlete. Physiol Rep 2015;3(12):e12645. doi: 10.14814/phy2.12645 Martín-EscuderoP Muñoz-GuerraJ Del PradoN Galindo CanalesM Fuentes FerrerM VargasS SoldevillaAB Serrano-GardeE Miguel-TobalF Maestro de Las CasasM Fernandez-PérezC Impact of UGT2B17 gene deletion on the steroid profile of an athlete Physiol Rep 2015 3 12 e12645 10.14814/phy2.12645 Open DOISearch in Google Scholar

52. Robinson N, Sottas PE, Schumacher YO. The athlete biological passport: how to personalize anti-doping testing across an athlete’s career? Med Sport Sci 2017;62:107–18. doi: 10.1159/000460722 RobinsonN SottasPE SchumacherYO The athlete biological passport: how to personalize anti-doping testing across an athlete’s career? Med Sport Sci 2017 62 107 18 10.1159/000460722 Open DOISearch in Google Scholar

53. Piper T, Thevis M. Applications of isotope ratio mass spectrometry in sports drug testing accounting for isotope fractionation in analysis of biological samples. Methods Enzymol 2017;596:403–32. doi: 10.1016/bs.mie.2017.07.013 PiperT ThevisM Applications of isotope ratio mass spectrometry in sports drug testing accounting for isotope fractionation in analysis of biological samples Methods Enzymol 2017 596 403 32 10.1016/bs.mie.2017.07.013 Open DOISearch in Google Scholar

54. Mareck U, Geyer H, Opfermann G, Thevis M, Schänzer W. Factors influencing the steroid profile in doping control analysis. J Mass Spectrom 2008;43:877–91. doi: 10.1002/jms.1457 MareckU GeyerH OpfermannG ThevisM SchänzerW Factors influencing the steroid profile in doping control analysis J Mass Spectrom 2008 43 877 91 10.1002/jms.1457 Open DOISearch in Google Scholar

55. Prommer N, Sottas PE, Schoch C, Schumacher YO, Schmidt W. Total hemoglobin mass-a new parameter to detect blood doping? Med Sci Sports Exerc 2008;40:2112–8. doi: 10.1249/MSS.0b013e3181820942 PrommerN SottasPE SchochC SchumacherYO SchmidtW Total hemoglobin mass-a new parameter to detect blood doping? Med Sci Sports Exerc 2008 40 2112 8 10.1249/MSS.0b013e3181820942 Open DOISearch in Google Scholar

56. Pottgiesser T, Echteler T, Sottas PE, Umhau M, Schumacher YO. Hemoglobin mass and biological passport for the detection of autologous blood doping. Med Sci Sports Exerc 2012;44:835–43. doi: 10.1249/MSS.0b013e31823bcfb6 PottgiesserT EchtelerT SottasPE UmhauM SchumacherYO Hemoglobin mass and biological passport for the detection of autologous blood doping Med Sci Sports Exerc 2012 44 835 43 10.1249/MSS.0b013e31823bcfb6 Open DOISearch in Google Scholar

57. Schumacher YO, Pottgiesser T. The impact of acute gastroenteritis on haematological markers used for the Athletes Biological Passport - report of 5 cases. Int J Sports Med 2011;32:147–50. doi: 10.1055/s-0030-1268463 SchumacherYO PottgiesserT The impact of acute gastroenteritis on haematological markers used for the Athletes Biological Passport - report of 5 cases Int J Sports Med 2011 32 147 50 10.1055/s-0030-1268463 Open DOISearch in Google Scholar

58. Athanasiadou I, Christian Voss S, El Saftawy W, Al-Maadheed M, Valsami G, Georgakopoulos C. Hyperhydration using different hydration agents does not affect the haematological markers of the athlete biological passport in euhydrated volunteers. J Sports Sci 2020;38:1924–32. doi: 10.1080/02640414.2020.1763772 AthanasiadouI Christian VossS El SaftawyW Al-MaadheedM ValsamiG GeorgakopoulosC Hyperhydration using different hydration agents does not affect the haematological markers of the athlete biological passport in euhydrated volunteers J Sports Sci 2020 38 1924 32 10.1080/02640414.2020.1763772 Open DOISearch in Google Scholar

59. Leuenberger N, Bulla E, Salamin O, Nicoli R, Robinson N, Baume N, Baume N, Saugy M. Hepcidin as a potential biomarker for blood doping. Drug Test Anal 2017;9:1093–7. doi: 10.1002/dta.2122 LeuenbergerN BullaE SalaminO NicoliR RobinsonN BaumeN BaumeN SaugyM Hepcidin as a potential biomarker for blood doping Drug Test Anal 2017 9 1093 7 10.1002/dta.2122 Open DOISearch in Google Scholar

60. Craviari C, Fossati C, Quaranta F, Tomassi G, Fagnani F, Borrione P. Hepcidin as possible new indirect biomarker for blood doping. Med Sport 2021;74:153–74. doi: 10.23736/S0025-7826.21.03877-1 CraviariC FossatiC QuarantaF TomassiG FagnaniF BorrioneP Hepcidin as possible new indirect biomarker for blood doping Med Sport 2021 74 153 74 10.23736/S0025-7826.21.03877-1 Open DOISearch in Google Scholar

61. Jeppesen JS, Breenfeldt Andersen A, Bonne TC, Thomassen M, Sørensen H, Nordsborg NB, Olsen NV, Huertas JR, Bejder J. Immature reticulocytes are sensitive and specific to low-dose erythropoietin treatment at sea level and altitude. Drug Test Anal 2021;13:1331–40. doi: 10.1002/dta.3031 JeppesenJS Breenfeldt AndersenA BonneTC ThomassenM SørensenH NordsborgNB OlsenNV HuertasJR BejderJ Immature reticulocytes are sensitive and specific to low-dose erythropoietin treatment at sea level and altitude Drug Test Anal 2021 13 1331 40 10.1002/dta.3031 Open DOISearch in Google Scholar

62. de la Torre X, Colamonici C, Curcio D, Botrè F. Fast IRMS screening of pseudoendogenous steroids in doping analyses. Drug Test Anal 2017;9:1804–12. doi: 10.1002/dta.2321 de la TorreX ColamoniciC CurcioD BotrèF Fast IRMS screening of pseudoendogenous steroids in doping analyses Drug Test Anal 2017 9 1804 12 10.1002/dta.2321 Open DOISearch in Google Scholar

63. de la Torre X, Jardines D, Botrè F. Evaluation of longitudinal ¹³C isotope ratio mass spectrometric data in antidoping analysis. Drug Test Anal 2022;14:1877–90. doi: 10.1002/dta.3339 de la TorreX JardinesD BotrèF Evaluation of longitudinal ¹³C isotope ratio mass spectrometric data in antidoping analysis Drug Test Anal 2022 14 1877 90 10.1002/dta.3339 Open DOISearch in Google Scholar

64. Ponzetto F, Mehl F, Boccard J, Baume N, Rudaz S, Saugy M, Nicoli R. Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports. Anal Bioanal Chem 2016;408:705–19. doi: 10.1007/s00216-015-9185-1 PonzettoF MehlF BoccardJ BaumeN RudazS SaugyM NicoliR Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports Anal Bioanal Chem 2016 408 705 19 10.1007/s00216-015-9185-1 Open DOISearch in Google Scholar

65. Salamin O, Mignot J, Kuuranne T, Saugy M, Leuenberger N. Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusion. Drug Test Anal 2018;10:604–8. doi: 10.1002/dta.2240 SalaminO MignotJ KuuranneT SaugyM LeuenbergerN Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusion Drug Test Anal 2018 10 604 8 10.1002/dta.2240 Open DOISearch in Google Scholar

66. Mussack V, Wittmann G, Pfaffl MW. On the trail of blood doping - microRNA fingerprints to monitor autologous blood transfusions in vivo. Am J Hematol 2021;96:338–53. doi: 10.1002/ajh.26078 MussackV WittmannG PfafflMW On the trail of blood doping - microRNA fingerprints to monitor autologous blood transfusions in vivo Am J Hematol 2021 96 338 53 10.1002/ajh.26078 Open DOISearch in Google Scholar

67. Marrocco C, Pallotta V, D’Alessandro A, Alves G, Zolla L. Red blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping. Blood Transfus 2012;10(Suppl 2):s71–7. doi: 10.2450/2012.011S MarroccoC PallottaV D’AlessandroA AlvesG ZollaL Red blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping Blood Transfus 2012 10 Suppl 2 s71 7 10.2450/2012.011S Open DOISearch in Google Scholar

68. World Anti-Doping Agency (WADA). Anti-Doping Testing Figures Report [displayed 26 January 2024]. Available at https://www.wadaama.org/en/resources/anti-doping-stats/anti-doping-testing-figures-report World Anti-Doping Agency (WADA) Anti-Doping Testing Figures Report [displayed 26 January 2024] Available at https://www.wadaama.org/en/resources/anti-doping-stats/anti-doping-testing-figures-report Search in Google Scholar

69. Equey T, Pastor A, de la Torre Fornell R, Thomas A, Giraud S, Thevis M, Kuuranne T, Baume N, Barroso O, Aikin R. Application of the athlete biological passport approach to the detection of growth hormone doping. J Clin Endocrinol Metab 2022;107:649–59. doi: 10.1210/clinem/dgab799 EqueyT PastorA de la Torre FornellR ThomasA GiraudS ThevisM KuuranneT BaumeN BarrosoO AikinR Application of the athlete biological passport approach to the detection of growth hormone doping J Clin Endocrinol Metab 2022 107 649 59 10.1210/clinem/dgab799 Open DOISearch in Google Scholar

70. Ericsson M, Bhuiyan H, Yousif B, Lehtihet M, Ekström L. The intra-individual stability of GH biomarkers IGF-I and P-III-NP in relation to GHRH administration, menstrual cycle, and hematological parameters. Drug Test Anal 2020;12:1620–8. doi: 10.1002/dta.2953 EricssonM BhuiyanH YousifB LehtihetM EkströmL The intra-individual stability of GH biomarkers IGF-I and P-III-NP in relation to GHRH administration, menstrual cycle, and hematological parameters Drug Test Anal 2020 12 1620 8 10.1002/dta.2953 Open DOISearch in Google Scholar

71. Erotokritou-Mulligan I, Eryl Bassett E, Cowan DA, Bartlett C, Milward P, Sartorio A, Sönksen PH, Holt RI. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score. Clin Endocrinol 2010;72:520–6. doi: 10.1111/j.1365-2265.2009.03668.x Erotokritou-MulliganI Eryl BassettE CowanDA BartlettC MilwardP SartorioA SönksenPH HoltRI The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score Clin Endocrinol 2010 72 520 6 10.1111/j.1365-2265.2009.03668.x Open DOISearch in Google Scholar